MENLO PARK, Calif., May 30, 2025 – GRAIL, Inc. (Nasdaq: GRAL), a healthcare company dedicated to early cancer detection with the aim of improving survival rates, has announced the granting of equity awards. These awards, in the form of restricted stock units (RSUs), cover a total of 77,350 shares of GRAIL’s common stock and have been granted to 38 newly hired, non-executive employees. The RSUs serve as a material incentive for accepting employment with GRAIL. These inducement awards were granted under GRAIL’s Inducement Equity Incentive Plan, following the guidelines of Nasdaq Listing Rule 5635(c)(4) and the related restricted stock award agreement.
The inducement plan is specifically designed for granting equity awards to individuals who are not current GRAIL employees, or who are re-joining after a significant break in employment. These awards are a key incentive for these individuals to accept employment at GRAIL, in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs will vest over approximately four years, with 25% of the award vesting on May 31, 2026, and the remaining portions vesting annually thereafter, contingent upon continued employment with GRAIL (or its successors or subsidiaries) through each vesting date.
About GRAIL
GRAIL is a healthcare company focused on detecting cancer early, when treatment is more likely to be successful. The company aims to reduce the global impact of cancer through advanced technologies including next-generation sequencing, large-scale clinical studies, and sophisticated machine learning, software, and automation. These tools are used to detect and identify multiple types of aggressive cancers at earlier stages. GRAIL’s methylation-based platform supports various aspects of cancer care, including multi-cancer early detection in patients showing symptoms, risk assessment, minimal residual disease detection, biomarker subtyping, and monitoring treatment and recurrence. GRAIL’s headquarters are located in Menlo Park, CA, with additional locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit .
SOURCE GRAIL, Inc.